HibMenCY
Trade name: Menhibrix
Vaccineapproved
Approved
Oct 24, 2012
Clinical trial activity
9 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
9
Phase 3
7
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00129129)
Timeline
Indications
Approved for
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Approval history
- approvedOct 24, 2012
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk792014
- haemophilus influenzae type b- and meningococcal vaccine
- hib-mency-tt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00345683 | Phase 3 | Jul 1, 2007 | GlaxoSmithKline |
| NCT00345579 | Phase 3 | Sep 1, 2006 | GlaxoSmithKline |
| NCT00322335 | Phase 3 | May 1, 2006 | GlaxoSmithKline |
| NCT00289783 | Phase 3 | Feb 1, 2006 | GlaxoSmithKline |
| NCT00134719 | Phase 2 | Apr 1, 2005 | GlaxoSmithKline |
| NCT00263653 | Phase 3 | Mar 1, 2005 | GlaxoSmithKline |
| NCT00258700 | Phase 3 | Feb 1, 2005 | GlaxoSmithKline |
| NCT00323050 | Phase 3 | Nov 1, 2004 | GlaxoSmithKline |
| NCT00129129 | Phase 2 | Aug 1, 2004 | GlaxoSmithKline |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 9 | 9 | 2 | 2004 |
1 organizations
Page 1 / 1